Robert J. Bird

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Incidence of aspirin resistance in high-risk patients following elective total hip and knee arthroplasty.

Incidence of aspirin resistance in high-risk patients following elective total hip and knee arthroplasty.

Journal: Internal medicine journal

Published: February 12, 2025

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

Journal: American journal of hematology

Published: October 29, 2024

Efficacy and Long-Term Outcomes of Eltrombopag Treatment Within 6 Months of Diagnosis in Patients With Steroid Unresponsive or Dependent Immune Thrombocytopenia.

Efficacy and Long-Term Outcomes of Eltrombopag Treatment Within 6 Months of Diagnosis in Patients With Steroid Unresponsive or Dependent Immune Thrombocytopenia.

Journal: American journal of hematology

Published: September 17, 2024

Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.

Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.

Journal: Blood advances

Published: October 27, 2023

Updated treatment options for immune thrombocytopenia.

Updated treatment options for immune thrombocytopenia.

Journal: Internal medicine journal

Published: July 28, 2023

The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.

The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.

Journal: The Lancet regional health. Western Pacific

Published: February 27, 2023

Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.

Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.

Journal: Journal of the Academy of Nutrition and Dietetics

Published: September 18, 2022

Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH).

Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH).

Journal: Blood research

Published: July 11, 2022

Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients.

Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients.

Journal: Research and practice in thrombosis and haemostasis

Published: June 30, 2022

Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.

Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 26, 2022

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report.

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report.

Journal: JTO clinical and research reports

Published: May 25, 2022

Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.

Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.

Journal: The New England journal of medicine

Published: April 13, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026